To download the full report, click here.

According to a recent survey of payer executives and specialty physicians conducted by Health Strategies Group, both payers and providers are interested in additional information from biopharmaceutical companies about prescription medicines – including information about pipeline medicines and unapproved uses of approved medicines. The survey underscores that increased access to more complete information about medicines would help payers make better-informed coverage decisions and allow providers to make better prescribing decisions for patients. Download the report to learn more.